Innate Immune Defenses Induced by CpG Do Not Promote Vaccine-Induced Protection against Foot-and-Mouth Disease Virus in Pigs

被引:47
作者
Alves, M. P. [1 ]
Guzylack-Piriou, L. [1 ]
Juillard, V. [2 ]
Audonnet, J. -C. [2 ]
Doel, T. [5 ]
Dawson, H. [3 ]
Golde, W. T. [4 ]
Gerber, H. [1 ]
Peduto, N. [1 ]
McCullough, K. C. [1 ]
Summerfield, A. [1 ]
机构
[1] Inst Virol & Immunoprophylaxis, CH-3147 Mittelhausern, Switzerland
[2] Merial SAS, Discovery Res, F-69342 Lyon 07, France
[3] USDA, Diet Gen & Immunol Lab, Beltsville Human Nutr Res Ctr, BARC E, Beltsville, MD 20705 USA
[4] ARS, Plum Isl Anim Dis Ctr, Foot & Mouth Dis Unit, USDA, Greenport, NY 11944 USA
[5] Merial Anim Hlth Ltd, Pirbright, England
关键词
EMERGENCY VACCINATION; INTERFERON-ALPHA; CONTACT TRANSMISSION; SUBUNIT VACCINE; OLIGODEOXYNUCLEOTIDE; INFECTION; RESPONSES; MICE; DNA; OLIGONUCLEOTIDES;
D O I
10.1128/CVI.00018-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Emergency vaccination as part of the control strategies against foot-and-mouth disease virus (FMDV) has the potential to limit virus spread and reduce large-scale culling. To reduce the time between vaccination and the onset of immunity, immunostimulatory CpG was tested for its capacity to promote early protection against FMDV challenge in pigs. To this end, CpG 2142, an efficient inducer of alpha interferon, was injected intramuscularly. Increased transcription of Mx1, OAS, and IRF-7 was identified as a sensitive measurement of CpG-induced innate immunity, with increased levels detectable to at least 4 days after injection of CpG formulated with Emulsigen. Despite this, CpG combined with an FMD vaccine did not promote protection. Pigs vaccinated 2 days before challenge had disease development, which was at least as acute as that of unvaccinated controls. All pigs vaccinated 7 days before challenge were protected without a noticeable effect of CpG. In summary, our results demonstrate the caution required when translating findings from mouse models to natural hosts of FMDV.
引用
收藏
页码:1151 / 1157
页数:7
相关论文
共 28 条
[1]  
Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9
[2]   Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets [J].
Alves, M. P. ;
Neuhaus, V. ;
Guzylack-Piriou, L. ;
Ruggli, N. ;
McCullough, K. C. ;
Summerfield, A. .
GENE THERAPY, 2007, 14 (10) :836-844
[3]   Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease [J].
Barnard, AL ;
Arriens, A ;
Cox, S ;
Barnett, P ;
Kristensen, B ;
Summerfield, A ;
McCullough, KC .
VACCINE, 2005, 23 (08) :1037-1047
[4]   Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine [J].
Barnett, PV ;
Cox, SJ ;
Aggarwal, N ;
Gerber, H ;
McCullough, KC .
VACCINE, 2002, 20 (25-26) :3197-3208
[5]   Novel viral disease control strategy: Adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease [J].
Chinsangaram, J ;
Moraes, MP ;
Koster, M ;
Grubman, MJ .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1621-1625
[6]   Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission [J].
Cox, SJ ;
Barnett, PV ;
Dani, P ;
Salt, JS .
VACCINE, 1999, 17 (15-16) :1858-1868
[7]   Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha [J].
de Avila Botton, S ;
Brum, MCS ;
Bautista, E ;
Koster, M ;
Weiblen, R ;
Golde, WT ;
Grubman, MJ .
VACCINE, 2006, 24 (17) :3446-3456
[8]   EMERGENCY VACCINATION AGAINST FOOT-AND-MOUTH-DISEASE - RATE OF DEVELOPMENT OF IMMUNITY AND ITS IMPLICATIONS FOR THE CARRIER STATE [J].
DOEL, TR ;
WILLIAMS, L ;
BARNETT, PV .
VACCINE, 1994, 12 (07) :592-600
[9]  
Doel TR, 2005, CURR TOP MICROBIOL, V288, P103
[10]   An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response [J].
Dong, L ;
Mori, I ;
Hossain, MJ ;
Liu, BX ;
Kimura, Y .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :1623-1628